Challenging the concept that late recurrence and death from tumor are common after fractionated radiotherapy for benign meningioma.

CONCLUSION: Our results contradict the conclusion based on patients treated with surgery-alone that recurrence of benign meningioma is common with long-term follow-up. After fractionated radiotherapy, the 20-year control rate is approximately 90%. Our results confirm that a substantial percentage of recurrences present >10 years after treatment. These findings have important implications for the choice of initial treatment and follow-up duration. PMID: 31071515 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31071515?dopt=Abstract

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - May 5, 2019 Category: Radiology Authors: O'steen L, Amdur RJ, Morris CG, Mendenhall WM Tags: Radiother Oncol Source Type: research